Teacher Retirement System Of Texas Reata Pharmaceuticals Inc Transaction History

Teacher Retirement System Of Texas

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$79.22 - $105.37 $140,853 - $187,347	-1,778 Reduced 21.4%	6,531 $666,000
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $256,332 - $774,149	8,309 New	8,309 $755,000
Q4 2021 Feb 10, 2022	SELL	$25.61 - $110.96 $108,765 - $471,247	-4,247 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$100.0 - $143.02 $107,800 - $154,175	1,078 Added 34.02%	4,247 $427,000
Q2 2021 Aug 05, 2021	BUY	$78.27 - $151.29 $37,491 - $72,467	479 Added 17.81%	3,169 $449,000
Q1 2021 May 11, 2021	BUY	$94.25 - $132.81 $46,088 - $64,944	489 Added 22.22%	2,690 $268,000
Q4 2020 Feb 11, 2021	BUY	$102.03 - $184.62 $224,568 - $406,348	2,201 New	2,201 $272,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.